Lung cancer continues to represent one of the most critical public health challenges worldwide, primarily due to its high mortality rate and the persistent difficulty of achieving early and accurate diagnosis (Tang et al., 2025). Survival outcomes are strongly linked to the stage at which the disease is detected, yet many patients are diagnosed only after the cancer has advanced to an incurable phase (Ning et al., 2021). Imaging plays a central role in lung cancer screening and diagnosis, with computed tomography remaining the dominant modality. However, growing concerns regarding cumulative radiation exposure, coupled with the demand for improved diagnostic precision, have motivated the exploration of alternative imaging strategies (Abe and Nyathi, 2025; Nathani and Dincer, 2025). In this context, the convergence of magnetic resonance imaging and machine learning has emerged as a promising and rapidly evolving research domain within computer science and engineering.
Magnetic resonance imaging offers distinct advantages as a non-ionizing imaging technique with superior soft tissue contrast. Historically, its application to lung imaging was constrained by technical limitations such as low proton density in pulmonary tissue, susceptibility to motion artifacts, and long acquisition times (Kumar et al., 2016). Recent technological advances have significantly mitigated these challenges. Improvements in gradient hardware, fast pulse sequences, respiratory gating, and motion correction algorithms have enhanced the feasibility of thoracic MRI (Tischendorf et al., 2025). Additionally, functional MRI techniques, including diffusion-weighted imaging and dynamic contrast-enhanced imaging, provide quantitative insights into tissue microstructure and vascular characteristics, which are highly relevant for differentiating malignant from benign lesions (Sharma et al., 2022). These developments have positioned MRI as a viable and informative modality for lung cancer assessment, particularly when paired with data-driven analytical approaches.
Machine learning has fundamentally transformed medical image analysis by enabling automated pattern recognition at scales and levels of complexity beyond human capability (Currie et al., 2019). In the context of lung cancer detection, machine learning models are trained to identify discriminative features within MRI images that correspond to malignant pathology. Traditional machine learning pipelines often relied on handcrafted features derived from intensity distributions, texture measures, or morphological descriptors (Arshad et al., 2025). While informative, these approaches are limited by their dependence on expert-defined representations. The advent of deep learning, particularly convolutional neural networks, has shifted the paradigm toward end-to-end learning, where hierarchical features are automatically extracted from raw image data (Koishiyeva et al., 2025). This capability is especially valuable for MRI, where subtle spatial and intensity variations may encode critical diagnostic information.
The application of machine learning to MRI-based lung cancer detection involves a complex computational workflow. High-quality data acquisition is followed by preprocessing steps aimed at correcting noise, motion artifacts, and inter-scan variability (Gayap and Akhloufi, 2024). Given the sensitivity of learning algorithms to data quality, preprocessing remains a crucial engineering component of any successful system. Model training typically employs supervised learning, requiring carefully annotated datasets that link imaging findings with histopathological or clinical outcomes. Validation strategies such as cross-validation and independent testing cohorts are essential to ensure generalizability and to prevent overfitting, a common risk when working with limited medical datasets (Li et al., 2023).
One of the most significant challenges in this field is the scarcity and heterogeneity of lung MRI data. Compared to other imaging modalities, large-scale, standardized MRI datasets for lung cancer are relatively rare. Variations in scanner hardware, imaging protocols, and patient populations introduce additional complexity that can degrade model performance (Ma et al., 2025). From an engineering perspective, several strategies have been developed to address these constraints. Transfer learning enables models pre-trained on related imaging tasks to be adapted to lung MRI with reduced data requirements. Federated learning frameworks allow collaborative model training across institutions without centralized data sharing, preserving patient privacy while increasing dataset diversity (Kim et al., 2022). Synthetic data generation using advanced generative models further supports data augmentation and robustness. Beyond data limitations, pulmonary MRI presents unique technical challenges due to residual motion artifacts and signal variability. Machine learning models must therefore be designed to tolerate imperfect inputs while maintaining diagnostic accuracy. Recent architectural innovations, including attention mechanisms and multi-scale feature extraction, allow models to focus on clinically relevant regions and suppress background noise (Kaushik et al., 2025). These approaches exemplify the close interplay between algorithmic design and domain-specific engineering constraints that characterizes research at the intersection of computer science and medical imaging.
As machine learning models move closer to clinical application, issues of interpretability and trust become increasingly important. High classification accuracy alone is insufficient in a medical setting where decisions carry significant consequences. Clinicians require transparency regarding how and why a model arrives at a particular conclusion. Explainable artificial intelligence techniques, such as visualization of salient image regions influencing predictions, are therefore essential components of clinically deployable systems (Ennab and Mcheick, 2024). By enhancing interpretability, these methods help bridge the gap between automated analysis and human expertise, fostering acceptance and effective integration into radiological workflows. Evaluation of machine learning systems for lung cancer detection must extend beyond conventional accuracy metrics. Sensitivity and specificity are particularly critical, as false negatives can delay life-saving treatment while false positives may lead to unnecessary interventions. Rigorous validation across diverse patient cohorts and imaging environments is necessary to establish reliability. Moreover, comparative studies against expert radiologists and existing diagnostic standards provide meaningful benchmarks for assessing real-world utility (Durgam et al., 2025). From an engineering research perspective, such evaluations underscore the importance of system-level performance rather than isolated algorithmic success.
Ethical and regulatory considerations further shape the development and deployment of machine learning models in medical imaging. Ensuring data privacy, mitigating algorithmic bias, and complying with regulatory standards are integral to responsible innovation. Models trained on non-representative datasets risk perpetuating disparities in diagnostic performance across populations (Mohammed and Malhotra, 2025). Addressing these issues requires deliberate dataset curation, continuous monitoring, and interdisciplinary collaboration among engineers, clinicians, and policymakers. Regulatory approval processes demand robust evidence of safety and effectiveness, reinforcing the need for transparent methodologies and reproducible research practices. Looking ahead, the future of machine learning–based lung cancer detection using MRI lies in deeper integration of multimodal data and personalized medicine. Combining MRI with other imaging modalities, molecular biomarkers, and clinical data can yield more comprehensive diagnostic and prognostic models. Advances in computational efficiency and hardware acceleration may enable near real-time analysis, expanding the potential for point-of-care applications (Arshad et al., 2025). Open science initiatives and shared research platforms will play a vital role in accelerating progress, fostering collaboration, and ensuring reproducibility across the global research community.
The application of machine learning to MRI imaging for lung cancer detection represents a compelling convergence of computer science, engineering, and clinical medicine. While technical and practical challenges remain, ongoing advances in imaging technology, algorithm design, and data-sharing frameworks continue to push the boundaries of what is possible. For the Computer Science and Engineering Research Journal, this field exemplifies how computational innovation can directly contribute to addressing pressing healthcare challenges. Continued interdisciplinary research in this area holds the promise of safer, more accurate, and more accessible lung cancer diagnostics, ultimately improving patient outcomes and advancing the role of intelligent systems in modern medicine.

Acknowledgements

Not applicable.

Ethical approval statement

None to declare.

Data availability

Not applicable.

Informed consent statement

Not applicable.

Conflict of interest

The authors declare no conflict of interests.

Author contributions

Ishmat Jahan: Conceptualization, formal analysis, writing-original draft preparation, review and editing. The author has read and approved the final version of the published editorial.